Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.86 |
High Similarity |
NPD6190 |
Approved |
0.8599 |
High Similarity |
NPD3882 |
Suspended |
0.8535 |
High Similarity |
NPD3817 |
Phase 2 |
0.8481 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8408 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8345 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8344 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8323 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8261 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8242 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8239 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8239 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8221 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8129 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8125 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8095 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8072 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8063 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8063 |
Intermediate Similarity |
NPD37 |
Approved |
0.8047 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8036 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8025 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8025 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8025 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8025 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7976 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7975 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7965 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7929 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7917 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7901 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7898 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7862 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7844 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7815 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7808 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7758 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7742 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7736 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD919 |
Approved |
0.7707 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7706 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7682 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7661 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7647 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.763 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7619 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7613 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7582 |
Intermediate Similarity |
NPD943 |
Approved |
0.758 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.758 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7529 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7528 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7516 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7515 |
Intermediate Similarity |
NPD1247 |
Approved |
0.75 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7484 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7483 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7471 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7453 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7429 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7425 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7416 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7375 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7375 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7349 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7234 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7229 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7229 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7209 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7197 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7197 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7153 |
Intermediate Similarity |
NPD228 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7127 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7124 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7117 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7114 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7112 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD920 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7099 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7095 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7091 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7074 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7056 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7053 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7047 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6032 |
Approved |
0.701 |
Intermediate Similarity |
NPD7874 |
Approved |
0.701 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD5762 |
Approved |
0.6975 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6975 |
Remote Similarity |
NPD5763 |
Approved |
0.6974 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD1535 |
Discovery |
0.6973 |
Remote Similarity |
NPD7296 |
Approved |
0.6971 |
Remote Similarity |
NPD5711 |
Approved |
0.6971 |
Remote Similarity |
NPD5710 |
Approved |
0.6971 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD5647 |
Approved |
0.6959 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6957 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6954
|
Remote Similarity |
NPD17 |
Approved |